VA purchase of $1.2 billion in pharmaceutics termed a 'team failure'

NewsGuard 100/100 Score

These comments came during a Wednesday House Veterans Affairs Committee Hearing. Meanwhile, in other news related to veterans' health, USA Today reports that the return of combat troops is driving a medical-care backlog.  

The Washington Post: VA: Buying Medications Outside Of Contracts Was Just An Effort To Help Veterans
The Department of Veterans Affairs' purchase of $1.2 billion in pharmaceuticals since 2004 in violation of federal law and regulations was the result of "a team failure" at the department, VA Deputy Secretary W. Scott Gould told the House Veterans Affairs Committee on Wednesday (Vogel, 2/1).

USA Today: Combat Troop Ailments Drive Medical Backlog
Tens of thousands of combat troops who undergo routine health checks before returning home need treatment for ailments ranging from bad backs to mental illness, helping to drive a backlog of troops waiting for medical retirements, new Pentagon data show (Zoroya and Overberg, 2/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study demystifies clinicians' decision-making process for drug-drug interactions